These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2833847)

  • 1. Separation from uremic body fluids and normal urine of Na+, K+-ATPase inhibitor.
    Gallice P; Monti JP; Braguer D; Durand C; Manchon H; Murisasco A; Crevat A
    Adv Exp Med Biol; 1987; 223():215-8. PubMed ID: 2833847
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo accumulation of sodium pump inhibitor by normal and uremic erythrocytes.
    Gallice P; Lai E; Brunet P; Berland Y; Elsen R; Crevat A
    Int J Artif Organs; 1993 Mar; 16(3):120-2. PubMed ID: 8390969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 23Na nuclear magnetic resonance study of Na+-K+ pump inhibition by a fraction from uremic toxins.
    Gallice P; Monti JP; Baz M; Murisasco A; Crevat A
    Clin Chem; 1988 Oct; 34(10):2044-7. PubMed ID: 2844439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A circulating Na+-K+ATPase inhibitor, erythrocyte sodium transport and hypertension in patients with chronic renal failure.
    Kariya K; Sano H; Yamanishi J; Saito K; Furuta Y; Fukuzaki H
    Clin Exp Hypertens A; 1986; 8(2):167-83. PubMed ID: 2424645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dialysis on circulating Na,K ATPase inhibitor in uremic patients.
    Stokes GS; Norris LA; Marwood JF; Johnston H; Caterson RJ
    Nephron; 1990; 54(2):127-33. PubMed ID: 2156180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Na, K ATPase inhibitor from ultrafiltrate obtained by hemodialysis of patients with uremia.
    Sohn HJ; Stokes GS; Johnston H
    J Lab Clin Med; 1992 Aug; 120(2):264-71. PubMed ID: 1323635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of alteration of sodium potassium pump of erythrocytes from patients with chronic renal failure.
    Cheng JT; Kahn T; Kaji DM
    J Clin Invest; 1984 Nov; 74(5):1811-20. PubMed ID: 6094614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution NMR studies of transmembrane cation transport in uremic patients.
    Monti JP; Baz M; Elsen R; Berland YF; Crevat AD
    Biochim Biophys Acta; 1990 Aug; 1027(1):31-40. PubMed ID: 2168751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of dialysis on Na+/K+-ATP-ase activity in uremic children].
    Vásárhelyi B; Reusz G; Sallay P; Tulassay T
    Orv Hetil; 1996 Oct; 137(40):2193-6. PubMed ID: 8927368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Na-K ATPase inhibitor activity and intracellular ions during hemodialysis.
    Krzesinski JM; Du F; Pequeux ML; Rorive GL
    Int J Artif Organs; 1993 Jan; 16(1):23-30. PubMed ID: 8384605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of an endogenous Na+,K(+)-ATPase-specific inhibitor from pig urine.
    Tamura M; Harris TM; Konishi F; Inagami T
    Eur J Biochem; 1993 Jan; 211(1-2):317-27. PubMed ID: 8381085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous sodium pump inhibitors in human urine. Further identification of inhibitors of Na-K-ATPase.
    Kramer HJ; Krampitz G; Bäcker A; Michel H; Krampitz G; Meyer-Lehnert H
    Am J Hypertens; 1995 Jul; 8(7):753-60. PubMed ID: 7546503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Na,K-ATPase activity reduces Babesia gibsoni infection of canine erythrocytes with inherited high K, low Na concentrations.
    Yamasaki M; Takada A; Yamato O; Maede Y
    J Parasitol; 2005 Dec; 91(6):1287-92. PubMed ID: 16539007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technical aspects on middle molecules: separation, isolation, and identification.
    Cueille G; Man NK; Sausse A; Farges JP; Funck-Brentano JL
    Artif Organs; 1981; 4 Suppl():8-12. PubMed ID: 7295100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An inhibitor of nerve cell membrane Na,K-ATPase. Isolation and general characteristics].
    Elaev NR; Baĭgil'dina AA
    Biokhimiia; 1994 Mar; 59(3):389-94. PubMed ID: 8180271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and metabolic studies on red blood cell sodium transport in chronic uremia.
    Kramer HJ; Gospodinov D; Krück F
    Nephron; 1976; 16(5):344-58. PubMed ID: 131254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Purification of an endogenous inhibitor of sodium-potassium-ATPase].
    Cloix JF; Miller ED; Pernollet MG; Devynck MA; Meyer P
    C R Seances Acad Sci III; 1983 Feb; 296(5):213-6. PubMed ID: 6303528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium pump activity in uremic erythrocytes: a microcalorimetric study.
    Gallice P; Kovacic H; Baz M; Berland Y; Elsen R; Sari JC; Crevat A
    Int J Artif Organs; 1992 Mar; 15(3):135-8. PubMed ID: 1325947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of canrenone on Na+,K+ ATPase activity, arterial pressure and plasma potassium concentration in uremic hemodialyzed patients.
    Quarello F; Boero R; Guarena C; Rosati C; Beltrame G; Colombo P; Berto IM; Aimino M; Formica M; Piccoli G
    Adv Exp Med Biol; 1989; 252():371-6. PubMed ID: 2551145
    [No Abstract]   [Full Text] [Related]  

  • 20. Attenuation of Na/K-ATPase Mediated Oxidant Amplification with pNaKtide Ameliorates Experimental Uremic Cardiomyopathy.
    Liu J; Tian J; Chaudhry M; Maxwell K; Yan Y; Wang X; Shah PT; Khawaja AA; Martin R; Robinette TJ; El-Hamdani A; Dodrill MW; Sodhi K; Drummond CA; Haller ST; Kennedy DJ; Abraham NG; Xie Z; Shapiro JI
    Sci Rep; 2016 Oct; 6():34592. PubMed ID: 27698370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.